. Author manuscript; available in PMC: 2018 Jul 13.

Published in final edited form as: Breast Cancer Res Treat. 2015 Aug 7;153(1):211–218. doi: 10.1007/s10549-015-3528-7

Table 2.

Hazard ratio (HR, 95% CI) of cancer-specific mortality of AA breast cancer cases by subtype, SEER 2010 - 2012.

	No. Deaths (%) Case Fatality	Crude HR^* (95% CI)	Model 1 ^a ^* (95% CI)	Model 2 ^b ^* (95% CI)	Model 3^c ^* (95% CI)
Cancer Subtype
Her2+/HR+ (Ref)	145 (7.3)	-	-	-	-
Her2+/HR-	102 (10.3)	1.40 (1.08 – 1.80)	1.38 (1.07 – 1.77)	1.39 (1.08 – 1.79)	1.37 (1.06 – 1.77)
Her2-/HR+	706 (6.5)	0.89 (0.74 – 1.06)	0.79 (0.66 – 0.95)	1.01 (0.85 – 1.21)	1.02 (0.85 – 1.21)
TNBC	546 (14.3)	1.97 (1.64 – 2.36)	1.96 (1.63 – 2.35)	2.34 (1.95 – 2.81)	2.33 (1.94 – 2.80)
Unknown	502 (22.4)	2.89 (2.40 – 3.49)	2.55 (2.11 – 3.08)	1.42 (1.18 – 1.73)	1.43 (1.18 – 1.73)
p-value for breast cancer subtype		<0.001	<0.001	<0.001	<0.001

Adjusted for age only.

Adjusted for age, stage and treatment.

Adjusted for age, stage, treatment, % below poverty line, and % <9^th grade education.

Estimated from Cox proportional hazard model.